Bodisen Biotech Receives A Letter From American Stock Exchange

SHAANXI, China, Nov. 12, 2006 (PRIMEZONE) -- Bodisen Biotech, Inc. (AMEX:BBC), (LSE:BODI), (www.bodisen.com), today announced that, on November 6, 2006, the Company received a letter from the American Stock Exchange ("Amex") stating that the Staff had determined that the Company was not in compliance with certain of the Amex continued listing standards, specifically Sections 132(a), 132(e), and 403 of the Amex Company Guide, and need to be improved in the future.

Back to news